Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
Id | http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65364
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65364
|
---|---|
Preferred Name | Darunavir |
Definitions |
A human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir selectively targets and binds to the active site of HIV-1 protease, and inhibits the dimerization and catalytic activity of HIV-1 protease. This inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions, and prevents HIV replication.
|
Synonyms |
(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate
DARUNAVIR
Darunavir
TMC114
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
label |
Darunavir
|
---|---|
Legacy Concept Name |
Darunavir
|
CHEBI_ID |
CHEBI:367163
|
Preferred_Name |
Darunavir
|
Semantic_Type |
Pharmacologic Substance
|
prefixIRI |
Thesaurus:C65364
|
DEFINITION |
A human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir selectively targets and binds to the active site of HIV-1 protease, and inhibits the dimerization and catalytic activity of HIV-1 protease. This inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions, and prevents HIV replication.
|
UMLS_CUI |
C1435444
|
code |
C65364
|
Chemical_Formula |
C27H37N3O7S
|
subClassOf | |
type | |
CAS_Registry |
206361-99-1
|
FULL_SYN |
(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate
DARUNAVIR
Darunavir
TMC114
|
FDA_UNII_Code |
YO603Y8113
|
Contributing_Source |
FDA
|
Concept_In_Subset |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |